42
Participants
Start Date
March 17, 2018
Primary Completion Date
December 3, 2021
Study Completion Date
December 3, 2021
sutimlimab (BIVV009)
Pharmaceutical form: solution for injection Route of administration: intravenous (i.v.)
placebo
Pharmaceutical form: solution for injection Route of administration: intravenous (i.v.)
Medical University of Vienna, Vienna
Academisch Medisch Centrum, Amsterdam
Gemeinschaftspraxis Hämatologie-Onkologie, Dresden
ZNA Stuivenberg, Antwerp
Leids Universitair Medisch Centrum, Leiden
University Hospitals Leuven, Leuven
Monash Medical Centre, Clayton
Ballarat Oncology & Haematology, Ballarat
USC Health Clinics, Buderim
Haukeland University Hospital, Bergen
Perth Blood Institute, West Perth
St Olavs Hospital, Avdeling for blodsykdommer, Trondheim
Montefiore Medical Center, New York
New York Medical College at Westchester Medical Center, Valhalla
Hôpital de Caen, Caen
University of Pittsburgh Medical Center, Pittsburgh
Hospital of the University of Pennsylvania, Philadelphia
Georgetown University Medical Center, Georgetown
Fondazione IRCSS Ca' Granda Ospedale Maggiore Policlinico, Milan
A. O. Spedali Civili di Brescia, Brescia
East Carolina University, Greenville
Hospital Universitario Puerta de Hierro, Majadahonda
Cleveland Clinic Florida, Weston
U.O.C. Ematologia Ospedale San Bortolo, Vicenza
Hospital Universitario Virgen del Rocio, Seville
Cleveland Clinic, Cleveland
Universitätsklinikum Essen, Essen
Hospital Universitario Dr. Peset, Valencia
CHU d'Angers, Angers
UW Hospitals and Clinics, Madison
Washington University School of Medicine, St Louis
Centre Hospitalier Lyon Sud, Pierre-Bénite
Arizona Oncology Associates PC, Tucson
Univ Ulm, Inst Klin. Transfusions. Immungen, Ulm
USC/Keck School of Medicine, Los Angeles
Hadassah Medical Center, Jerusalem
Centre Hospitalier Henri Mondor, Créteil
Laniado Hospital, Netanya
Ishikawa Prefectural Central Hospital, Kanazawa
Massachusetts General Hospital, Boston
Brigham and Women's Hospital, Boston
St. Michael's Hospital, Toronto
McGill University Health Center, Montreal
"U.O.C. Ematologia- Policlinico A. Gemelli", Rome
Japanese Red Cross Society Himeji Hospital, Himeji
Tokai University Hospital, Isehara
Osaka University Hospital, Suita
Saitama Medical University Hospital, Iruma-gun
Aichi Medical University Hospital, Nagakute
Hospital Clinci i Provincial de Barcelona, Barcelona
St James Hospital, Leeds, Leeds
Imperial College Healthcare NHS Trust, Hammersmith Hospital, London
University College London, London
Bioverativ, a Sanofi company
INDUSTRY